BIOLIFE SOLUTIONS INC (BLFS) research

BIOLIFE SOLUTIONS INC
ShareXLinkedInReddit
Sector
Healthcare
Industry
Medical Instruments & Supplies
Last price
$37.18
As of

BIOLIFE SOLUTIONS INC (BLFS): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-09.

As of . Source: SEC EDGAR filings for BLFS. Method and limitations.

SHARE THIS CARD

Share the BLFS intelligence card

A branded snapshot of BLFS: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion BLFS intelligence card preview
Post to X
LIVE TERMINAL

See BLFS live in the terminal

Track BLFS's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live BLFS terminal, free

Active signals for BLFS

FREE, NO ACCOUNT

Every signal on BLFS, as it fires

You are seeing 5 of 23 signals recorded on BLFS since 2026-05-29.

The five above landed across 2 days. The other 18 were recorded on 2 other days. 19 of the 23 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in BLFS (2026Q2)

Manager / securityMarket value% portfolioQoQ
MILLENNIUM MANAGEMENT LLCCUSIP 09062W204 · 2026Q2$17.7M0.01%,
CITADEL ADVISORS LLCCUSIP 09062W204 · 2026Q2$4.5M0.00%,
Point72 Asset Management, L.P.CUSIP 09062W204 · 2026Q2$989K0.00%,
D. E. Shaw & Co., Inc.CUSIP 09062W204 · 2026Q2$349K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, BLFS

BLFS against its peers

BLFS's operating margin of -17.3% ranks in the 29th percentile of 18 Medical Instruments & Supplies sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.

MetricBLFSPeer medianPercentilen
Revenue FY96.2M USD86.3M USD5616
Gross margin64.6%54.7%8516
Operating margin-17.3%2.6%2918
Net margin-4.8%-3.2%5018
Return on equity-1.2%-5.6%5317
P / En/a21.4xn/a5

Peers (19): KMTS, AVR, ICUI, STVN, MMED, BLCO, SMTI, EMBC, NNNN, OSUR, UTMD, PDEX, ZJYL, NYXH, KRMD, STXS, ALC, MBOT, NEPH. Left out: AZTA (no annual filing), PLSE (no annual filing), SOAGY (no annual filing), SDMHF (no annual filing), DXR (no annual filing), ZTEK (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (BLFS: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more BLFS signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to BLFSand get the insider, 13F, options, and confluence read in one view.

Open the live BLFS terminal, free